Screening for inherited metabolic disease in Wales using urine-impregnated filter paper

Insights

This study screened 135,295 infants for metabolic disorders using urine tests. While detecting several conditions, it found o-hydroxyphenlacetic acid unreliable for screening phenylketonuria.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Medical Diagnostics

Background:

  • Newborn screening is crucial for early detection of inborn errors of metabolism.
  • Filter paper urine testing offers a non-invasive method for mass screening.
  • Accurate diagnostic markers are essential for effective newborn screening programs.

Purpose of the Study:

  • To evaluate the efficacy of filter paper urine analysis for detecting various metabolic abnormalities in a large infant cohort.
  • To assess the reliability of specific urinary constituents, particularly o-hydroxyphenlacetic acid, as screening markers for phenylketonuria.

Main Methods:

  • Collected urine specimens on filter paper from 135,295 infants.
  • Utilized spot tests and paper chromatography to analyze for 7 abnormal urinary constituents.
  • Compared results with established diagnostic criteria for metabolic disorders.

Main Results:

  • Identified 5 cases of phenylketonuria, 4 of histidinaemia, 5 of cystinuria, 5 of diabetes mellitus, and 1 of alcaptonuria.
  • Observed transient abnormalities including tyrosyluria, generalized aminoaciduria, cystinuria, and glycosuria.
  • Found 2 phenylketonuric infants who did not excrete detectable o-hydroxyphenlacetic acid, indicating a screening limitation.

Conclusions:

  • Filter paper urine testing is effective in detecting a range of metabolic disorders in newborns.
  • The detection of o-hydroxyphenlacetic acid is an unreliable sole method for screening phenylketonuria.
  • Further refinement of screening methods is necessary to ensure comprehensive detection of all affected infants.